The use of interleukin 23 inhibitors in patients with chronic hepatitis B infection: A case series.

Ch'en, Peter Yi; Farrer, Sterling; Miranda-Cacdac, Lauren; Song, Eingun James

Ch'en, Peter Yi; Farrer, Sterling; Miranda-Cacdac, Lauren; Song, Eingun James.

Afiliación

Ch'en PY; Albert Einstein College of Medicine, Bronx, New York.
Farrer S; Silver Falls Dermatology, Salem, Oregon.
Miranda-Cacdac L; A.T. Still University-School of Osteopathic Medicine in Arizona, Mesa, Arizona.
Song EJ; North Sound Dermatology, Mill Creek, Washington.

JAAD Case Rep ; 30: 1-4, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36337283

Palabras clave

ALT, alanine aminotransferase; AST, aspartate aminotransferase; BSA, body surface area; HBV; HBV, hepatitis B virus; IL, interleukin; IL-23; IL-23 inhibitors; PGA, physician global assessment; TNF-α, tumor necrosis factor-alfa; biologics; case series; chronic inactive hepatitis B; guselkumab; hepatitis B; plaque psoriasis; risankizumab; tildrakizumab; treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google